Literature DB >> 10095355

[Phototherapeutic keratectomy (PTK) after epidemic keratoconjunctivitis].

C D Quentin1, M Tondrow, M Vogel.   

Abstract

BACKGROUND: Persistent and recurrent nummuli after epidemic keratokonjunktivitis (EKC) often lead to reduced visual acuity and increased glare. In spite of long-term topical steroid therapy nummuli often recur. We tried to treat persistent nummuli with phototherapeutic keratectomy (PTK). PATIENTS: PTK with an excimer laser (193 nm) was performed in 13 eyes of 9 patients with nummuli. The nummuli were observed over 3-72 months (mean: 36 months). Preoperatively, the visual acuity was 0.1-0.9 (mean: 0.39 +/- 0.22) and the brightness acuity test (BAT) was 0.05-0.5 (mean: 0.25 +/- 0.15). Prior to PTK all eyes had been treated with local steroids several times for recurrent nummuli.
RESULTS: During the follow-up from 15 to 56 months (mean: 33 +/- 11.5 ms), 11 eyes had an increase in visual acuity: 0.3-1.0 (mean: 0.63 +/- 0.26). The reduction of glare was especially beneficial for the patients: 0.3-0.9 (mean: 0.55 +/- 0.21). One patient had a recurrence of nummuli in both eyes 6 weeks after PTK. The subjective-induced spheric refractive change was -2.5 D to +2.0 D. The astigmatic error changed between -2.0 D to +1.5 D.
CONCLUSION: PTK seems to be an effective method of treating persistent, recurrent nummuli after EKC. The low rate of recurrence of nummuli after PTK is remarkable.

Entities:  

Mesh:

Year:  1999        PMID: 10095355     DOI: 10.1007/s003470050381

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  4 in total

1.  [Phototherapeutic keratectomy (o-PTK) with 193 nm excimer laser for superficial corneal scars. Prospective long-term results of 31 consecutive operations].

Authors:  A Hafner; B Seitz; A Langenbucher; G O H Naumann
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

Review 2.  Epidemic keratoconjunctivitis: the current situation and recommendations for prevention and treatment.

Authors:  Birthe Meyer-Rüsenberg; Ulrike Loderstädt; Gisbert Richard; Paul-Michael Kaulfers; Caroline Gesser
Journal:  Dtsch Arztebl Int       Date:  2011-07-08       Impact factor: 5.594

3.  [Adenoviral keratoconjunctivitis].

Authors:  U Pleyer; F Birnbaum
Journal:  Ophthalmologe       Date:  2015-05       Impact factor: 1.059

4.  Adenoviral keratoconjunctivitis.

Authors:  Alexander Bialasiewicz
Journal:  Sultan Qaboos Univ Med J       Date:  2007-04
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.